The STD Panel Advance is a sexually transmitted infection (STI) screening package that includes 9 tests to assess selected infections, including HIV, syphilis, hepatitis B, hepatitis C, herpes simplex virus (HSV), and chlamydia. The package uses blood-based antibody and antigen tests to help identify evidence of certain infections or immune responses. It may support sexual health screening, investigation of possible STI exposure, and further medical evaluation.
Fasting
Not required
Report time
Within 72-96 hours
Recommended for
Male & Female
Age group
18–99 years
Tests
9 tests
Parameters
9 parameters
The STD Panel Advance is a laboratory screening package designed to assess selected sexually transmitted infections through blood testing.
Also known as: Advanced STD Test Panel, STI Screening Package, Comprehensive STD Blood Test, Sexual Health Screening Panel, Advanced STI Blood Test Package.
Sexually transmitted infections can spread through sexual contact, including vaginal, anal, or oral sex. Certain infections may also spread through blood exposure or from mother to child.
Some STIs cause noticeable symptoms, while others may remain asymptomatic for long periods.
This package includes investigations for:
These investigations may provide information about infection status or previous exposure. However, the included antibody tests have important limitations, and some are not recommended as primary tests for diagnosing active infections.
A healthcare professional may recommend additional or confirmatory investigations depending on symptoms, exposure history, and initial results.
The STD Panel Advance may be considered for:
Note: This package may not be the most appropriate first-line screening option for every individual. Test selection should consider symptoms, sexual practices, exposure timing, and current clinical guidelines.
The STD Panel Advance is a blood-based screening package containing nine tests for selected infections, including HIV, syphilis, hepatitis B, hepatitis C, herpes simplex virus, and chlamydia.
The package includes 9 tests covering 9 listed parameters.
No. Fasting is not required for this package.
Yes. It includes HIV 1 & 2 antibody testing using a qualitative CMIA method.
| Package name | STD Panel Advance |
|---|---|
| Location | Mohali |
| Sample type | Blood |
| Number of tests | 9 |
| Number of parameters | 9 |
| Home sample collection | Available |
| Fasting | Not required |
| Report time | Within 72-96 hours |
| Recommended age | 18–99 years |
| Suitable for | Male & Female |
# What Is Included in the STD Panel Advance?
The package includes nine laboratory investigations covering several important sexually transmitted infections.
### 1. Chlamydia Trachomatis IgM Antibodies
This test measures IgM antibodies against Chlamydia trachomatis.
It may indicate an immune response, but IgM antibody testing is not considered a reliable method for diagnosing active genital chlamydia infection.
A nucleic acid amplification test (NAAT), using urine or an appropriate swab, is generally preferred.
### 2. Hepatitis B Surface Antigen (HBsAg), Quantitative
This test measures hepatitis B surface antigen in the blood.
The presence of HBsAg can indicate a current hepatitis B infection. Additional hepatitis B markers may be required to determine infection status and clinical significance.
### 3. Herpes Simplex Virus (HSV) 1 & 2 IgM Antibodies
This test measures combined IgM antibodies against HSV-1 and HSV-2.
HSV IgM testing is not recommended for diagnosing genital herpes because results can be misleading and cannot reliably distinguish recent infection from recurrence.
### 4. Herpes Simplex Virus (HSV) 1 & 2 IgG Antibodies
This test measures combined IgG antibodies against herpes simplex viruses.
A positive result may indicate previous HSV exposure, but a combined result cannot reliably identify the virus type or location of infection.
Type-specific HSV IgG testing may be more informative in selected situations.
### 5. VDRL Test
The VDRL test is a nontreponemal blood test used in syphilis evaluation.
It detects antibodies associated with syphilis but may also produce false-positive results.
Results are generally interpreted alongside a treponemal test such as TPHA.
### 6. Hepatitis C Antibody (HCV), Quantitative
This test measures antibodies against the hepatitis C virus.
A positive antibody result may indicate current infection, previous resolved infection, or occasionally a false-positive result.
HCV RNA testing is generally needed to determine whether an active infection is present.
### 7. Treponema Pallidum Hemagglutination Assay (TPHA)
TPHA is a treponemal antibody test used in the evaluation of syphilis.
It helps detect antibodies against Treponema pallidum, the bacterium responsible for syphilis.
A positive result can persist after successful treatment, so it does not independently establish active infection.
### 8. HIV 1 & 2 Antibodies (CMIA Qualitative)
This test screens for antibodies against HIV-1 and HIV-2.
It may help identify HIV infection after antibodies have developed.
A negative result during the window period does not reliably exclude recent infection. Laboratory-based fourth-generation HIV antigen/antibody testing is generally preferred for routine screening.
### 9. Chlamydia Trachomatis IgG Antibodies
This test measures IgG antibodies against Chlamydia trachomatis.
Antibodies may reflect previous exposure and do not independently establish an active genital infection.
NAAT testing is generally preferred for diagnosing current chlamydia infection.
# Why Is the STD Panel Advance Done?
A healthcare professional may recommend STI testing to:
STI testing may be considered if you experience:
Many STIs cause no symptoms. The appropriate tests depend on the type of exposure and the time since exposure.
Important: This panel does not include gonorrhea testing or the recommended NAAT for active chlamydia. It should not be described as a complete screening panel for all sexually transmitted infections.
# Benefits of the STD Panel Advance
# Preparation Before the Test
The STD Panel Advance primarily requires a blood sample.
Testing window periods matter. Some infections cannot be detected immediately after exposure. A healthcare professional may recommend a different test or repeat testing at an appropriate time.
If you may have been exposed to HIV within the last 72 hours, seek urgent medical care to discuss post-exposure prophylaxis (PEP). Do not wait for routine panel results.
# Healthy Tips for Maintaining Sexual Health
# Who Should Book This Package?
The STD Panel Advance may be considered for:
Note: This package may not be the most appropriate first-line screening option for every individual. Test selection should consider symptoms, sexual practices, exposure timing, and current clinical guidelines.
Yes. It includes quantitative HBsAg testing for hepatitis B and hepatitis C antibody testing.
Yes. It includes both VDRL and TPHA, which are used together in the evaluation of syphilis.
Yes. It includes combined HSV-1 and HSV-2 IgG and IgM antibody tests. However, HSV IgM testing is not recommended for diagnosis, and combined antibody tests have important limitations.
Yes. It includes chlamydia IgG and IgM antibody tests. These are not the preferred tests for diagnosing active genital chlamydia infection. A urine or swab NAAT is generally recommended.
No. It does not test for every STI. For example, it does not include gonorrhea testing or standard NAAT-based screening for active chlamydia.
You can undergo testing, but results obtained too soon after exposure may be negative even if an infection is present. Appropriate testing depends on the infection and its detection window.
No. Negative results do not exclude all infections, particularly after recent exposure or when the included tests are not the preferred diagnostic methods.
No. A reactive screening result requires follow-up according to the applicable HIV diagnostic testing algorithm.
The included antibody-only test may not detect HIV during early infection. A fourth-generation HIV antigen/antibody test or HIV RNA test may be more appropriate depending on exposure timing.
A hepatitis C antibody result alone cannot confirm active infection. HCV RNA testing is generally required after a reactive antibody result.
Yes. The included blood investigations can be performed in adults of any sex when clinically appropriate.
Home blood sample collection may be available through OnHealth in supported locations, subject to partner laboratory availability.
Reports are generally available within 72–96 hours after sample collection, subject to laboratory processing.
Testing frequency depends on sexual activity, exposure history, symptoms, pregnancy status, and individual risk factors. A healthcare professional can recommend an appropriate screening schedule.
| City Name | Prices |
|---|---|
| STD Panel Advance in Agra | ₹3,399 |
| STD Panel Advance in Ahmedabad | ₹3,399 |
| STD Panel Advance in Ajmer | ₹3,399 |
| STD Panel Advance in Aligarh | ₹3,399 |
| STD Panel Advance in Amravati | ₹3,399 |